Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 38751-38800 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05904964
Disitamab Vedotin (RC48) in Hormone Receptor Positive, HER2-low Metastatic Breast Cancer (the Rosy Trial)
PHASE3Recruiting
288 participants
Started: Jul 1, 2023 · Completed: Mar 1, 2030
1 condition1 sponsor3 locations
NCT06390423
Passive Leg Raise and Mini-fluid Challenge Effect on Various Cardiac Output Surrogates for Fluid Responsiveness
N/ARecruiting
64 participants
Started: Jul 1, 2023 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT05925309
Preventive Effect of Prophylactic Oral Antibiotics Against Cholangitis After Kasai Portoenterostomy
NARecruiting
356 participants
Started: Jul 1, 2023 · Completed: Jul 31, 2027
3 conditions1 sponsor1 location
NCT05718882
Lenvatinib Plus VIC-1911 in Lenvatinib-unresponsive or Lenvatinib-resistant HCC
NARecruiting
30 participants
Started: Jul 1, 2023 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT06526572
Pain Measured by NRS and EEG in Acute Pulpitis
N/ARecruiting
50 participants
Started: Jul 1, 2023 · Completed: Jan 31, 2025
1 condition1 sponsor1 location
NCT05180760
Smartphone App for Non-alcoholic Fatty Liver Disease
NARecruiting
260 participants
Started: Jul 1, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05903001
Diaphragmatic Function as a Biomarker
N/ARecruiting
800 participants
Started: Jul 1, 2023 · Completed: Jun 30, 2025
6 conditions1 sponsor1 location
NCT05911503
Clinical Study of High Concentration Ganciclovir Eye Drops in the Treatment of Cytomegalovirus Retinitis
EARLY_PHASE1Recruiting
15 participants
Started: Jul 1, 2023 · Completed: Jun 30, 2027
2 conditions1 sponsor1 location
NCT06304389
Effect of Blue Light on Vagus Nerve Stimulation in Patients With Refractory Epilepsy
NARecruiting
34 participants
Started: Jul 1, 2023 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT05998200
Safety of Serum for Post-Inflammatory on Hyperpigmentation Skin
NARecruiting
34 participants
Started: Jul 1, 2023 · Completed: Oct 30, 2025
1 condition1 sponsor1 location
NCT06071403
The Effects of Time Points to Cease Parenteral Nutrition and IGF-1 on Very Low Birth Weight Infants
N/ARecruiting
416 participants
Started: Jul 1, 2023 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT06354465
Injectable Extended-Release Buprenorphine (XR-B) in a Correctional Setting: Qualitative Interviews
N/ARecruiting
25 participants
Started: Jul 1, 2023 · Completed: Jul 1, 2024
3 conditions2 sponsors1 location
NCT05692713
Polyomic Biomarker Verification in Adult Chronic Graft-Versus-Host Disease (ABLE3.0/CTTC2201)
N/ARecruiting
320 participants
Started: Jul 1, 2023 · Completed: Jun 30, 2025
5 conditions1 sponsor10 locations
NCT06500182
The Benefits of Hippotherapy for Patients With Parkinson's Disease of 75 Years
NARecruiting
36 participants
Started: Jul 1, 2023 · Completed: Jul 31, 2024
1 condition1 sponsor1 location
NCT05887284
Investigation of the Clinical Efficacy of Low-dose Ionizing Radiation in the Treatment of Osteoarthritis
NARecruiting
132 participants
Started: Jul 1, 2023 · Completed: Dec 31, 2028
2 conditions2 sponsors1 location
NCT05978609
Cadonilimab With Chemotherapy in Treating Advanced Biliary Cancer
PHASE2Recruiting
65 participants
Started: Jul 1, 2023 · Completed: Jul 1, 2026
1 condition1 sponsor1 location
NCT04686526
Wearable Electrocardiogram Monitoring Device and Smartphone Application in Perioperative Pain Management
N/ARecruiting
91 participants
Started: Jul 1, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06404762
Tuberosity Versus Palatal Connective Tissue Graft on the Treatment of Single Maxillary Recession-type Defects
NARecruiting
30 participants
Started: Jul 1, 2023 · Completed: Feb 1, 2025
1 condition1 sponsor1 location
NCT06200402
Antibiotic-Loaded Cement Versus Non-Antibiotic-Loaded Cement in Hip Prosthesis Surgery for Proximal Femur Fractures
NARecruiting
450 participants
Started: Jul 1, 2023 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT05821322
Blood Glucose Target Before and During Exercise in Adults With Type 1 Diabetes Using an Artificial Pancreas
NARecruiting
32 participants
Started: Jul 1, 2023 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT06432842
Knee Osteoarthritis and Rehabilitation
NARecruiting
30 participants
Started: Jul 1, 2023 · Completed: Jun 30, 2024
1 condition1 sponsor1 location
NCT06152484
Evolution of a Novel Optical Coherence Tomography Based Index in Diagnosing Keratoconus
N/ARecruiting
200 participants
Started: Jul 1, 2023 · Completed: Apr 1, 2024
1 condition1 sponsor1 location
NCT05904340
Transcutaneous Electrical Acupoint Stimulation on Symptoms Associated with Chemotherapy Induced Peripheral Neuropathy
NARecruiting
86 participants
Started: Jul 1, 2023 · Completed: Apr 30, 2025
2 conditions2 sponsors1 location
NCT05710185
Deucravacitinib for the Treatment of Palmoplantar Pustulosis
PHASE4Recruiting
18 participants
Started: Jul 1, 2023 · Completed: Jun 1, 2026
1 condition2 sponsors2 locations
NCT05927935
First-line Treatment for Femoroacetabular Impingement Syndrome
NARecruiting
120 participants
Started: Jul 1, 2023 · Completed: Jul 1, 2027
1 condition7 sponsors6 locations
NCT05888584
Improving Access and Recruitment to Clinical Trials for Lung Cancer Patients
NARecruiting
100 participants
Started: Jul 1, 2023 · Completed: Mar 30, 2025
1 condition2 sponsors9 locations
NCT06001489
The Effects of 360-degree Virtual Reality on Pre-procedural Anxiety in Patients Awaiting Elective Cardiac Surgery Involving a Sternotomy
NARecruiting
100 participants
Started: Jul 1, 2023 · Completed: Dec 31, 2024
4 conditions1 sponsor1 location
NCT05632913
Alpha Radiation Emitters Device for the Treatment of Recurrent Lung Cancer
NARecruiting
10 participants
Started: Jul 1, 2023 · Completed: Feb 28, 2027
2 conditions1 sponsor1 location
NCT06190847
Oral Microbiome is Associated With the Response to Chemoradiotherapy in Initial Inoperable Patients With Esophageal Squamous Cell Cancer
N/ARecruiting
97 participants
Started: Jul 1, 2023 · Completed: Jul 1, 2026
3 conditions1 sponsor1 location
NCT05925790
Clinical Phenotypes in Pericarditis: IL-1RA Antibodies and suPAR Levels
N/ARecruiting
146 participants
Started: Jul 1, 2023 · Completed: Dec 20, 2025
1 condition9 sponsors9 locations
NCT06282770
Photobiomodulation for Lower Back Pain Post Spinal Fusion and Decompression Surgery
NARecruiting
80 participants
Started: Jul 1, 2023 · Completed: Dec 1, 2025
2 conditions1 sponsor2 locations
NCT06017986
The Effect of Processing on Food Reward
NARecruiting
74 participants
Started: Jul 1, 2023 · Completed: Jul 1, 2026
1 condition1 sponsor1 location
NCT06076603
Comparison of Epithelial Lining Fluid and Blood Pharmacokinetics and Pharmacodynamics of Intravenous and Intravenous Plus Nebulized Polymyxin B in Multidrug Resistant Bacteria Ventilator-associated Pneumonia Patients
N/ARecruiting
30 participants
Started: Jul 1, 2023 · Completed: Aug 1, 2024
4 conditions1 sponsor1 location
NCT05997862
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
PHASE1/PHASE2Recruiting
24 participants
Started: Jul 1, 2023 · Completed: Mar 31, 2026
2 conditions1 sponsor1 location
NCT05916781
Effectiveness of Mycophenolate Mofetil Combined With Tacrolimus for Steroid Tapering in Systemic Lupus Erythematosus
PHASE4Recruiting
220 participants
Started: Jul 1, 2023 · Completed: Jul 31, 2026
2 conditions2 sponsors1 location
NCT06097962
Safety and Efficacy of NK510 to Treat NSCLC
EARLY_PHASE1Recruiting
9 participants
Started: Jul 1, 2023 · Completed: Jul 1, 2026
1 condition2 sponsors1 location
NCT05833594
Whole-course Immunonutrition Combined With Chemoradiotherapy±ICIs for Local Advanced Patients With Inoperable Esophageal Squamous Cell Carcinoma
N/ARecruiting
70 participants
Started: Jul 1, 2023 · Completed: Dec 1, 2026
4 conditions1 sponsor1 location
NCT05342740
Study of Biomarkers in Diabetic Chronic Wounds
N/ARecruiting
930 participants
Started: Jul 1, 2023 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT05436860
PreDEA Study, Prevention in Emergency / Acceptance Departments: the Case of Hepatic Steatosis
N/ARecruiting
20,189 participants
Started: Jul 1, 2023 · Completed: Jul 1, 2024
1 condition1 sponsor1 location
NCT06495034
Airwave Compression Therapy to Prevent Breast Cancer-related Lymphedema
NARecruiting
132 participants
Started: Jul 1, 2023 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05968742
Variation in Gingival Inflammatory Responses
NARecruiting
80 participants
Started: Jun 30, 2023 · Completed: Dec 31, 2027
1 condition2 sponsors1 location
NCT05702502
Assessing the Presence of CT-DNA in Lymphoma Associated HLH
N/ARecruiting
12 participants
Started: Jun 30, 2023 · Completed: Jan 1, 2026
2 conditions1 sponsor1 location
NCT05631912
TRAC Locus-inserted CD19-targeting STAR-T Cell Therapy in r/r B-NHL
PHASE1/PHASE2Recruiting
38 participants
Started: Jun 30, 2023 · Completed: Dec 15, 2025
1 condition1 sponsor2 locations
NCT05940233
Comparison of Rate of Complete Abortion Between Letrozole Plus Misoprostol vs Misoprostol Alone
NARecruiting
70 participants
Started: Jun 30, 2023 · Completed: May 30, 2025
1 condition1 sponsor1 location
NCT05800899
Trial of a Culturally Informed Brief Intervention to Reduce Alcohol Related Health Disparities and Treatment Inequities Among Latinxs
NARecruiting
600 participants
Started: Jun 30, 2023 · Completed: Jun 30, 2027
1 condition4 sponsors1 location
NCT05607121
TMS Visual Modulation in Body Dysmorphic Disorder
NARecruiting
40 participants
Started: Jun 30, 2023 · Completed: Oct 1, 2025
1 condition2 sponsors1 location
NCT06638723
Enhancing Motor Function in Individuals with Lower Limb Amputation
NARecruiting
20 participants
Started: Jun 30, 2023 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05870475
Pegylated Interferon α-2b in Combination With Ruxolitinib for Treating Hydroxyurea-resistant/Intolerant PV
PHASE2Recruiting
94 participants
Started: Jun 30, 2023 · Completed: May 31, 2028
1 condition1 sponsor1 location
NCT05519579
Intrathecal Chemoprophylaxis to Prevent Neurotoxicity Associated With Blinatumomab Therapy for Acute Lymphoblastic Leukemia
PHASE2Recruiting
20 participants
Started: Jun 30, 2023 · Completed: Dec 1, 2025
1 condition1 sponsor1 location
NCT06174597
Umbilical Cord Artery-derived Perivascular Stem Cells for the Critical Limb Ischemia Therapy
EARLY_PHASE1Recruiting
40 participants
Started: Jun 30, 2023 · Completed: Jun 30, 2026
1 condition1 sponsor1 location